Quick Summary:
In an ever-evolving healthcare landscape, staying informed about significant markets is key to impactful decision-making. Our detailed report on the global market for Benign Prostatic Hyperplasia Devices provides an invaluable resource for those seeking to understand this rapidly growing industry.
Estimated at US$499.1 million in 2022 and projected to reach US$734.6 million by 2030, this market is on a remarkable growth course. With a comprehensive analysis of critical segments like TURP and Laser Therapy, the report sheds light on potential investment opportunities. Get in-depth insights into noteworthy geographic markets like the US, China, Japan, Canada and Germany, each exhibiting promising CAGR over the next decade.
Get an edge over the competition with our special coverage on vital market players like Boston Scientific Corporation, Karl Storz GmbH & Co., Lumenis Ltd., Olympus Corporation, and more. Significantly, each purchase comes with complimentary updates for a year, ensuring you stay ahead of the curve with the latest industry trends and developments.
Global Benign Prostatic Hyperplasia Devices Market to Reach $734.6 Million by 2030
The global market for Benign Prostatic Hyperplasia Devices estimated at US$499.1 Million in the year 2022, is projected to reach a revised size of US$734.6 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030. TURP, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$353.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Laser Therapy segment is readjusted to a revised 5.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $149.6 Million, While China is Forecast to Grow at 4.7% CAGR
The Benign Prostatic Hyperplasia Devices market in the U.S. is estimated at US$149.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$129.5 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.Select Competitors (Total 38 Featured) -
- Boston Scientific Corporation
- Karl Storz GmbH & Co. KG
- Lumenis Ltd.
- Olympus Corporation
- Teleflex Inc.
- Urologix, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Benign Prostatic Hyperplasia Devices?
What is the growth rate of the Global Market for Benign Prostatic Hyperplasia Devices?
What is the forecasted size of the Global Market for Benign Prostatic Hyperplasia Devices?
Who are the key companies in the Global Market for Benign Prostatic Hyperplasia Devices?
Report Attribute | Details |
---|---|
No. of Pages | 192 |
Published | December 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 499.1 Million |
Forecasted Market Value ( USD | $ 734.6 Million |
Compound Annual Growth Rate | 5.0% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Boston Scientific Corporation
- Karl Storz GmbH & Co. KG
- Lumenis Ltd.
- Olympus Corporation
- Teleflex Inc.
- Urologix, Inc.